Arkolith/Insider Trading/TWST/Form 4

Leproust Emily M.

Chief Executive Officer, DirectorTwist Bioscience Corp (TWST) · full profile →Form 4 · filed Jun 1, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.1M
Net Open-Market Flow
-$1.1M
Transactions
6
5 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 28, 2026Option exercise(M)16K$8.82$145K863K
May 28, 2026Sell(S)1K$65.33$97K862K
May 28, 2026Sell(S)900$66.85$60K861K
May 28, 2026Sell(S)8K$67.95$518K853K
May 28, 2026Sell(S)6K$68.61$444K847K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 28, 2026Option exercise(M)16K—$075K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001214659-26-006967) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML